Comparing two oral depression treatments in adults
Treatments studied
Part of Mental health clinical trials.
This study tests a new antidepressant tablet against an approved one to see which works better and is safer for adults with major depression. It may help find a more effective option for treating depressive symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 to 65 years old
- Diagnosis of major depressive disorder (single or recurrent, without psychotic features)
- Current depressive episode lasting at least 3 months for first episode, or at least 1 month for recurrent
- Not currently taking certain antidepressants or willing to stop them before and during the trial
- Willing to attend study visits and complete questionnaires about mood and safety
- Willing to use effective contraception if of childbearing potential
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called KH607 for adults with major depressive disorder (MDD). It aims to see if the drug can reduce depression symptoms over time. Participants must stop other depression medications before starting and will be monitored closely.
This study tests a new combination of two medications (dextromethorphan and bupropion) as a treatment for major depressive disorder. It may be an option if you have not already tried many antidepressants that didn't work.
This study tests a new medicine called ammoxetine for people with major depression. It aims to see if it can help reduce depressive symptoms.
This trial tests an investigational medication for adults with major depressive disorder who are currently taking an antidepressant but still have symptoms. It aims to see if adding this new drug can improve mood better than a placebo.
This study tests an investigational medication (CYB003) for people with major depression whose current antidepressant isn't working well enough. It looks at whether this treatment can help improve depression symptoms.
This trial tests a new medicine called LV232 for people with moderate to severe depression. Researchers want to find the best dose and check if it works safely.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.